Physician profile
Anne K Narayan
NPI 1851544100
$846.55
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $174 · 2021: $141 · 2022: $108 · 2023: $132 · 2024: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $265.50 | 2020-2024 | |
| Allergan, INC. | $115.51 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $101.40 | 2019-2023 | |
| Organon LLC | $67.59 | 2021-2022 | |
| Exact Sciences Corporation | $62.97 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $31.07 | 2020 | |
| Exeltis, USA INC. | $30.11 | 2019-2020 | |
| Biogen, INC. | $28.89 | 2024 | |
| Therapeuticsmd, INC. | $26.85 | 2019-2022 | |
| Astellas Pharma US INC | $25.13 | 2024 | Veozah |
| Mayne Pharma Commercial LLC | $23.12 | 2019 | |
| Hologic Sales and Service, LLC | $20.83 | 2019 | |
| Merck Sharp & Dohme LLC | $19.52 | 2019 | |
| Medicem INC. | $16.87 | 2022 | |
| Amag Pharmaceuticals, INC. | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Narayan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.